Jubilant Pharma Limited · 1 week ago
Associate Director, Product Management – Advanced Molecular Imaging
Jubilant Pharma Limited is seeking an Associate Director for Product Management in Advanced Molecular Imaging. This role focuses on leading the strategic evolution and global expansion of the PET/SPECT portfolio, combining product management expertise with marketing vision to ensure impactful healthcare solutions reach patients worldwide.
Health CareManufacturingPharmaceutical
Responsibilities
Define and execute the long-term vision for PET/SPECT products, ensuring competitive positioning in North America and global markets
Develop pricing and market access strategies that balance profitability and patient reach
Monitor industry trends and competitor activity to identify growth and innovation opportunities
Build compelling go-to-market strategies for new product introductions, leveraging NDA, 505(b)(2), and ANDA pathways
Create branding, trademark, and promotional campaigns that differentiate our products in the molecular imaging space
Lead cross-functional launch planning with R&D, regulatory, manufacturing, and commercial teams
Drive international growth by tailoring strategies to regional market dynamics
Collaborate with commercial teams to adapt positioning and promotional strategies for local markets
Identify strategic partnerships and licensing opportunities to accelerate global reach
Inspire and guide cross-functional teams to deliver on portfolio priorities
Present strategies to governance teams and influence decision-making at the highest level
Establish clear performance metrics and ensure timely execution of product initiatives
Qualification
Required
Advanced degree in Life Sciences, Chemistry, Radiopharmaceuticals, Business, or related field
8+ years in product management, with at least 5 years in advanced molecular imaging and/or oncology
Expertise in market access, reimbursement, and competitive pricing strategies
Proven success in global product launches and lifecycle management
Strong understanding of PET/SPECT technologies and radiopharmaceutical distribution networks
Exceptional communication skills and a creative approach to branding and positioning
Preferred
MBA preferred
Company
Jubilant Pharma Limited
Jubilant Pharma Limited is a global integrated pharmaceutical company offering a wide range of products and services to our customers across geographies.
Funding
Current Stage
Late StageTotal Funding
$400MKey Investors
Standard Chartered Bank
2022-07-13Debt Financing· $400M
Recent News
The Times of India
2025-01-23
2025-01-23
Company data provided by crunchbase